3SBio Spin Off Mandi Banks On Hair Loss And Weight Loss Drugs In Hong Kong IPO Bid

3SBio Spin Off Mandi Banks On Hair Loss And Weight Loss Drugs In Hong Kong IPO Bid

  • January 7, 2026

Mandi’s IPO plan arrives at a time when Hong Kong’s capital markets are experiencing a remarkable revival. According to data from the London Stock Exchange Group, equity capital activity in the city has reached around seventy three billion dollars so far this year,

China’s 3SBio Seeks US$400 Million In Hong Kong To Expand Its Global Drug Pipeline

China’s 3SBio Seeks US$400 Million In Hong Kong To Expand Its Global Drug Pipeline

  • December 2, 2025

Chinese biopharmaceutical company 3SBio has launched a major fundraising effort as it aims to strengthen its drug development pipeline and expand its global footprint. The Shenyang-based firm announced plans to raise HK$3.12 billion, or roughly US$401 million, through a new share placement in